Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant expansion for access to JYNNEOS® by establishing additional pathways for vaccine procurement, distribution, and reimbursement by both…
Sandiola Signs 8 Independent, Community Hospitals to its Clinical Documentation Integrity Services and Technology Platform in 2023
Sandiola focuses on securing rightful reimbursement for independent, community hospitals for their patient care services. By providing both First and Second Level Clinical Documentation Integrity (CDI) reviews along with chart prioritization workflow technology, Sandiola ensures patient acuity is accurately captured…
